SequelSEC

Surgery Partners, Inc. SGRY

Services-General Medical & Surgical Hospitals, NEC · CIK 0001638833 · Fiscal year ends 1231

Revenue
$3.31B
Fiscal year ended 2025-12-31
Operating income
$389.50M
Fiscal year ended 2025-12-31
Free cash flow
$195.60M
Fiscal year ended 2025-12-31

Surgery Partners, Inc. (SGRY) reported revenue of $3.31B and net income of -$77.90M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Surgery Partners, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-General Medical & Surgical Hospitals, NEC.

Income

Surgery Partners, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312016-12-312015-12-31
Revenue$3.31B$3.11B$2.74B$2.54B$2.23B$1.86B$1.83B$1.77B$1.15B$959.89M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$1.41B$1.36B$821.20M$669.33M
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$290.56M
Operating income$389.50M$348.80M$328.00M$345.20M$302.20M$183.00M$235.90M$77.80M$196.48M$144.75M
Net income-$77.90M-$168.10M-$11.90M-$54.60M-$70.90M-$116.10M-$74.80M-$205.70M$9.45M$1.43M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 127.21Mshares 126.12Mshares 125.61Mshares 91.95Mshares 72.43Mshares 48.78Mshares 48.28Mshares 48.03Mshares 48.19Mshares 37.46M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expense$18.00M$134.60M-$300.00K$23.30M$10.50M-$20.10M$9.50M$26.40M$7.10M-$148.98M
Diluted EPS$-0.61$-1.33$-0.09$-0.59$-1.12$-3.19$-2.29$-4.96$0.20$0.04
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$118.20M$138.70M$120.90M$102.20M$104.00M$97.10M$88.60M$93.60M$60.25M$55.99M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Surgery Partners, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312016-12-312015-12-31
Cash & equivalents$239.90M$269.50M$195.90M$282.90M$389.90M$317.90M$92.70M$184.30M$69.70M$57.93M
Total assets$8.12B$7.89B$6.88B$6.68B$6.12B$5.41B$5.02B$4.68B$2.30B$2.10B
Current assets$1.15B$1.12B$895.00M$921.00M$946.10M$801.50M$525.50M$588.30M$361.96M$310.96M
Total liabilitiesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current liabilities$615.50M$624.40M$523.00M$493.40M$536.80M$556.80M$398.10M$349.30M$186.72M$181.29M
Total equity incl. NCI$3.13B$3.20B$3.03B$2.94B$1.97B$882.10M$983.40M$1.10B$324.70M$297.93M
Temporary (mezzanine) equity$395.50M$438.80M$327.40M$342.00M$330.20M$306.80M$395.00M$359.30M$180.52M$183.44M
Inventory$96.60M$88.40M$75.20M$71.40M$61.10M$56.40M$46.30M$43.40M$28.78M$25.59M
Accounts receivable$602.20M$579.10M$496.40M$456.30M$430.20M$382.20M$326.90M$307.60M$220.59M$177.76M
Goodwill$5.19B$5.07B$4.33B$4.14B$3.91B$3.47B$3.40B$3.38B$1.56B$1.41B
Long-term debt$3.60B$3.27B$2.70B$2.56B$2.88B$2.79B$2.52B$2.27B$1.41B$1.23B
Accounts payable$208.70M$208.70M$171.80M$151.60M$124.90M$100.20M$96.70M$83.30M$49.77M$45.34M

Cash flow

Surgery Partners, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312016-12-312015-12-31
Operating cash flow$274.30M$300.10M$293.80M$158.80M$87.10M$246.90M$129.50M$144.60M$125.24M$84.48M
Capital expenditures$78.70M$90.40M$88.80M$80.60M$57.60M$42.90M$73.60M$39.80M$39.11M$33.44M
Investing cash flow-$246.60M-$488.50M-$225.60M-$307.90M-$331.70M-$88.40M-$85.20M-$128.90M-$184.75M-$134.84M
Financing cash flow-$57.30M$262.00M-$155.20M$42.10M$316.30M$66.70M-$135.90M-$6.30M$71.28M$33.37M
Net change in cash-$29.60M$73.60M-$87.00M-$107.00M$71.70M$225.20M-$91.60M$9.40M$11.77M-$16.99M
Stock-based compensation$14.80M$33.30M$17.70M$18.40M$17.40M$13.20M$10.20M$9.30M$2.02M$7.50M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailable$0$0$2.00M$0$0
Depreciation & amortization$176.00M$152.60M$118.10M$114.80M$98.80M$94.80M$76.50M$67.40M$39.55M$34.54M

Derived

Surgery Partners, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312016-12-312015-12-31
Free cash flow$195.60M$209.70M$205.00M$78.20M$29.50M$204.00M$55.90M$104.80M$86.13M$51.04M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable30.3%
Operating margin11.8%11.2%12.0%13.6%13.6%9.8%12.9%4.4%Unavailable15.1%
FCF margin5.9%6.7%7.5%3.1%1.3%11.0%3.1%5.9%Unavailable5.3%
SBC / revenue0.4%1.1%0.6%0.7%0.8%0.7%0.6%0.5%Unavailable0.8%
Current ratio1.87x1.79x1.71x1.87x1.76x1.44x1.32x1.68x1.94x1.72x
Revenue YoY growth6.2%13.5%8.0%14.1%19.6%1.6%3.4%Unavailable19.3%Unavailable
Net margin-2.4%-5.4%-0.4%-2.2%-3.2%-6.2%-4.1%-11.6%Unavailable0.1%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue2.4%2.9%3.2%3.2%2.6%2.3%4.0%2.2%Unavailable3.5%
Long-term debt / equity1.15xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable4.12x
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SGRY in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-03-02View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-12View SEC filing

Companies in the same industry

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2019-12-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2018-12-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2016-12-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.